Background: MEN1, which codes for the protein menin, is a tumor suppressor in neuroendocrine tissue. In cholangiocarcinoma (CCA) cell lines the overexpression of menin decreased proliferation, angiogenesis, migration, and invasion in vitro and in xenografts, but its expression in CCA tumor tissue samples is not established.
Objective: Determine whether the expression of menin correlates with disease progression in patient samples of CCA in a tissue microarray (TMA) by immunohistochemical (IHC) staining.
Results: IHC analysis of 97 biopsies revealed that low-grade tumors (Grade I) exhibited intense, diffuse, finely granular nuclear menin immunoreactivity with a pronounced linear perinuclear pattern (mean IHC score = 2.00), whereas high-grade tumors (Grade III) mostly lacked such staining (mean IHC score = 0.35). Collectively, there was a significant inverse association between tumor grade and menin staining (P = 0.0005). We also found a significant association between fibrosis status and menin staining, in that, 81.2% (56/69) of patients without fibrosis had no menin staining, whereas 92.9% (26/28) patients with fibrosis exhibited menin staining (P < 0.0001). No association was found between fibrosis status and grade. Overall, menin expression is inversely associated with tumor grade and positively associated with fibrosis status.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923918 | PMC |
| http://dx.doi.org/10.1186/s13104-023-06282-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A AML with a simultaneous false positive rearrangement: FISH interpretation pitfalls.
Hematology
December 2024
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Introduction: rearrangement () is a common genomic alteration in acute leukemia that can be effectively targeted by menin inhibitors. While FISH is the standard laboratory test for , false positives can occur.
Case Report: We present a case of AML in which both and were identified by karyotype analysis and FISH.
Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
Virchows Arch
May 2024
Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Primary hyperparathyroidism with parathyroid tumors is a typical manifestation of Multiple Endocrine Neoplasia Type 1 (MEN1) and is historically termed "primary hyperplasia". Whether these tumors represent a multi-glandular clonal disease or hyperplasia has not been robustly proven so far. Loss of Menin protein expression is associated with inactivation of both alleles and a good surrogate for a MEN1 gene mutation.
View Article and Find Full Text PDFMultiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.
Front Endocrinol (Lausanne)
December 2023
Department of Surgery, National Hospital Organization Hakodate Hospital, Hakodate, Hokkaido, Japan.
Article Synopsis
- MEN1 is a genetic disorder that leads to multiple tumors in various organs, caused by mutations in the menin gene; this study focused on a Japanese family with MEN1 and Zollinger-Ellison syndrome (ZES).
- The family members exhibited several tumors, including NETs and other types, and their treatment outcomes highlighted the importance of pancreaticoduodenectomy for ZES management.
- The results indicated that long-term monitoring is critical for pulmonary NETs due to the risk of metastasis, and variations in menin immunohistochemistry might reflect tumor development rather than serving as a reliable diagnostic marker.
Loss of tumor suppressor menin expression in high grade cholangiocarcinomas.
BMC Res Notes
February 2023
Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, LA, 71103, USA.
Background: MEN1, which codes for the protein menin, is a tumor suppressor in neuroendocrine tissue. In cholangiocarcinoma (CCA) cell lines the overexpression of menin decreased proliferation, angiogenesis, migration, and invasion in vitro and in xenografts, but its expression in CCA tumor tissue samples is not established.
Objective: Determine whether the expression of menin correlates with disease progression in patient samples of CCA in a tissue microarray (TMA) by immunohistochemical (IHC) staining.
Loss of MEN1 leads to renal fibrosis and decreases HGF-Adamts5 pathway activity via an epigenetic mechanism.
Clin Transl Med
August 2022
Department of Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Background: Renal fibrosis is a serious condition that results in the development of chronic kidney diseases. The MEN1 gene is an epigenetic regulator that encodes the menin protein and its role in kidney tissue remains unclear.
Methods: Kidney histology was examined on paraffin sections stained with hematoxylin-eosin staining.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!